Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Alexopoulou

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biomarkers in Medicine|August 16, 2014
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patientsDimitra K Alexopoulou, Christos K Kontos, Spyridon Christodoulou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 17, 2014
Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinomaSpyridon Christodoulou, Dimitra K Alexopoulou, Christos K Kontos, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 14, 2011
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancerMaroulio Talieri, Dimitra K Alexopoulou, Andreas Scorilas, et al.
British Journal of Cancer|April 16, 2009
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancerM Talieri, L Li, Y Zheng, et al.
Thrombosis and Haemostasis|April 8, 2009
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancerMaroulio Talieri, Konstantina Mathioudaki, Panagiotis Prezas, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biomarkers in Medicine|August 16, 2014
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patientsDimitra K Alexopoulou, Christos K Kontos, Spyridon Christodoulou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 17, 2014
Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinomaSpyridon Christodoulou, Dimitra K Alexopoulou, Christos K Kontos, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 14, 2011
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancerMaroulio Talieri, Dimitra K Alexopoulou, Andreas Scorilas, et al.
British Journal of Cancer|April 16, 2009
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancerM Talieri, L Li, Y Zheng, et al.
Thrombosis and Haemostasis|April 8, 2009
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancerMaroulio Talieri, Konstantina Mathioudaki, Panagiotis Prezas, et al.
Pageof 2